PAR Technology Corporation, together with its subsidiaries, provides omnichannel cloud-based hardware and software solutions to the worldwide. The company offers PUNCHH, an enterprise-grade customer loyalty and engagement solution; PAR ORDERING, an e-commerce platform; PAR RETAIL, a digital engagement software solution; and PLEXURE, an international customer engagement and loyalty platform under the ENGAGEMENT CLOUD. It also provides PAR POS, a point-of-sale solution; TASK, an enterprise-grade technology solution; PAR OPS, which includes Data Central and Delaget; and PAR PAY, such as PAR payment services, and merchant services under the OPERATOR CLOUD. In addition, the company offers point-of-sale terminals and tablets, wireless headsets, drive-thru systems, kitchen display systems, kiosks, printers, payment devices, and other in-store peripherals. Further it provides services, such as hardware repair, installation and implementation, training, and on-site and technical support services. It serves enterprise restaurants, franchisees, and other restaurant outlets and to C-Stores; and other retail customers, including amusement parks, cinemas, cruise lines, spas, casinos, and other ticketing and entertainment venues. The company was founded in 1968 and is headquartered in New Hartford, New York.

PAR Technology Corporation

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has issued an update. Paradigm Biopharmaceuticals has disclosed a change in the interests of director Pau...

Paradigm Biopharmaceuticals Director Converts Options Into Shares

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has provided an update. Paradigm Biopharmaceuticals has applied to the ASX for quotation of 176,880 new o...

Paradigm Biopharmaceuticals Seeks ASX Quotation for Additional Ordinary Shares

Sun Pharma Advanced Research Co. Ltd. ( ($IN:SPARC) ) just unveiled an announcement. Trading in Sun Pharma Advanced Research Company Limited shares...

Exchange Seeks Clarification After Surge in Sun Pharma Advanced Research Trading Volume

Parker-Hannifin Corp (($PH)) has held its Q2 earnings call. Read on for the main highlights of the call. Parker-Hannifin’s latest earnings call str...

Parker-Hannifin Lifts Outlook After Record Quarter

Wells Fargo Sticks to Their Buy Rating for Parker Hannifin (PH)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Par Technology (PAR – Research Report) and Western D...

Analysts Offer Insights on Technology Companies: Par Technology (PAR) and Western Digital (WDC)

Paradigm Biopharmaceuticals ( ($AU:PAR) ) just unveiled an announcement. Paradigm Biopharmaceuticals reported continued operational progress in the...

Paradigm Expands Global Phase 3 Knee Osteoarthritis Trial as Peer-Reviewed Data Bolster iPPS Case

An update from Park Dental Partners, Inc. ( ($PARK) ) is now available. On January 29, 2026, Park Dental Partners, Inc. announced that it will hold...

Park Dental Sets 2026 Annual Shareholder Meeting Timeline

An announcement from Inter Parfums ( ($IPAR) ) is now available. On January 28, 2026, Interparfums, Inc. announced that its subsidiary Interparfums...

Inter Parfums Secures Long-Term David Beckham Fragrance License

Inter Parfums ( ($IPAR) ) has provided an update. On January 28, 2026, Interparfums, Inc. announced that its U.S. subsidiary has signed an exclusiv...

Inter Parfums Secures Long-Term Global Nautica Fragrance License

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on LENZ Therapeutics (LENZ – Research Report) and Park ...

Analysts Offer Insights on Healthcare Companies: LENZ Therapeutics (LENZ) and Park Dental Partners, Inc. (PARK)

Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Inter Parfums (IPAR – Research Report) and Bel...

Analysts Offer Insights on Consumer Goods Companies: Inter Parfums (IPAR) and BellRing Brands (BRBR)

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Inter Parfums (IPAR – Research Report) and Ingre...

Analysts Are Bullish on These Consumer Goods Stocks: Inter Parfums (IPAR), Ingredion (INGR)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Par Technology (PAR – Research Report) and Lantronix...

Analysts Are Bullish on Top Technology Stocks: Par Technology (PAR), Lantronix (LTRX)

An update from Inter Parfums ( ($IPAR) ) is now available. On January 26, 2026, Interparfums, Inc. announced a 15-year extension of its exclusive w...

Inter Parfums Extends Long-Term Global GUESS Fragrance License

Looking for top-rated stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings from Top Wall Street ...

3 Best Stocks to Buy Today, 1/26/2026, According to Top Analysts

Par Drugs and Chemicals Limited ( ($IN:PAR) ) has provided an announcement. Par Drugs and Chemicals Limited has notified the stock exchange that th...

Par Drugs and Chemicals Alerts Investors to New IEPFA Helpline Number

Inter Parfums ( ($IPAR) ) has issued an announcement. Interparfums, Inc. reported that on January 21, 2026 it achieved record net sales for the fou...

Inter Parfums Announces Record Q4 and 2025 Sales

The latest announcement is out from Paras Defence & Space Technologies Ltd. ( ($IN:PARAS) ). Paras Defence & Space Technologies Ltd. has approved t...

Paras Defence to Form Semiconductor Packaging Subsidiary Focused on AI and HPC

Sun Pharma Advanced Research Co. Ltd. ( ($IN:SPARC) ) has provided an announcement. Sun Pharma Advanced Research Company Limited has notified stock...

Sun Pharma Advanced Research Publishes EGM Notice in Line with SEBI Disclosure Norms

Sun Pharma Advanced Research Co. Ltd. ( ($IN:SPARC) ) just unveiled an announcement. Sun Pharma Advanced Research Company Limited has called an ext...

SPARC Calls February EGM to Approve Preferential Issue of Convertible Warrants

Stephens analyst maintained a Buy rating on Par Technology today and set a price target of $60.00. In addition to Stephens, Par Technology also rec...

Par Technology (PAR) Receives a Buy from Stephens

An announcement from Paradigm Biopharmaceuticals ( ($AU:PAR) ) is now available. Paradigm Biopharmaceuticals has applied for quotation on the ASX o...

Paradigm Biopharmaceuticals Seeks ASX Quotation for Nearly 5 Million New Shares

In a report released today, Eric Martinuzzi from Lake Street maintained a Buy rating on Par Technology, with a price target of $48.00. Martinuzzi c...

Lake Street Remains a Buy on Par Technology (PAR)

Analysts have been eager to weigh in on the Energy sector with new ratings on Frontline (FRO – Research Report), Obsidian Energy (OBE – Research Re...

Analysts Offer Insights on Energy Companies: Frontline (FRO), Obsidian Energy (OBE) and Parex Resources (OtherPARXF)

Analysts have been eager to weigh in on the Energy sector with new ratings on Magnolia Oil & Gas (MGY – Research Report) and Par Pacific Holdings (...

Analysts Conflicted on These Energy Names: Magnolia Oil & Gas (MGY) and Par Pacific Holdings (PARR)

The latest announcement is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals has advised holders of its PAROA quoted ...

Current Quarter	$-0.1	Next Quarter	$-0.08
Current Year	$-0.58	Next Year	$0.11
QoQ Growth	+20.0%	YoY Growth	+119.0%
3Y EPS CAGR	+64.1%	Target Price	$56.88
Consensus	Buy	Upside	+150.0%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PAR	$22.75	-7.75%	3.17M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PAR	$22.75	-7.7%	3.17M
3
4
5
6

PAR

PAR

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get PAR Technology Corporation Data in Excel

Get PAR Technology Corporation Data in Excel